The World Medical Innovation Forum brings together Mass General Brigham and presenting sponsor Bank of America to advance patient benefiting technologies. Join us, May 2–4, along with dozens of CEOs, investors and top MDs.
The 2022 Forum will explore the promise of new gene and cell therapies, the challenges to their development and investment and market dynamics. GCT is widely recognized as a transformational opportunity in medicine, with the potential to stop or slow the effects of disease by targeting it at the genetic level.
May 2–4, 2022
Gene and cell therapy holds immense potential to advance the quality of patient care, reduce cost, and improve outcomes. Systemic complexity, however, can hinder the translation of breakthroughs to clinical care.
Our collective mission: finding solutions to the medical, operational, and economic challenges confronting GCT-driven care to ensure that patients, providers, and healthcare organizations benefit as soon as possible.
Engage with peers from across the GCT and machine learning ecosystem. Meet other executives, decision-makers, and business leaders from health care, pharma, medical devices, and biotech.
Clinicians and Investigators
The one event where physician and clinical leaders connect with peers across the medical landscape. Attend plenary panels, networking events, and fireside chats to capture insight into how GCT and other technology is enhancing the care continuum.
Join leaders from across the spectrum of government roles. Learn about the priorities of officials who are leading government agencies.
Connect with the executives who are determining how gene and cell therapy will be reimbursed.
Attendees by Industry
Life Sciences and Biotech
Gene and Cell Therapy
Clinician, Investigator, Hospital Staff
Venture and Investment
Non-Profit, Government, Media